EpiVario
Philadelphia, US · Founded 2017
Biotech
Founders & leadership
TK
Thomas KimExecutive Officer, Director
ES
Eric SchultenoverDirector
MD
Michael DishowitzDirector
Reported raises · per SEC filings
Form D private placements$125KraisedJan 2024 · 3 investors · Pharmaceuticals
Rule 506(b)$135KraisedSep 2022 · 3 investors · Pharmaceuticals
Rule 506(b)$233KraisedAug 2021 · 9 investors · Pharmaceuticals
Rule 506(b)$599.5KraisedMar 2020 · 23 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.